| Breakdown | Mar 2026 | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 604.83B | 562.40B | 540.15B | 456.48B | 389.90B |
| Gross Profit | 276.39B | 267.53B | 254.96B | 204.78B | 173.01B |
| EBITDA | 107.60B | 106.39B | 101.32B | 64.08B | 48.33B |
| Net Income | 58.11B | 52.12B | 61.69B | 38.92B | 21.27B |
Balance Sheet | |||||
| Total Assets | 795.62B | 718.28B | 672.87B | 618.64B | 555.97B |
| Cash, Cash Equivalents and Short-Term Investments | 217.55B | 188.75B | 139.88B | 121.44B | 117.69B |
| Total Debt | 34.24B | 34.05B | 32.88B | 57.07B | 54.05B |
| Total Liabilities | 265.72B | 242.56B | 228.10B | 231.81B | 215.63B |
| Stockholders Equity | 520.02B | 467.86B | 436.64B | 379.63B | 333.57B |
Cash Flow | |||||
| Free Cash Flow | 74.83B | 88.18B | 55.12B | 31.79B | 43.36B |
| Operating Cash Flow | 85.95B | 99.03B | 63.83B | 40.42B | 51.64B |
| Investing Cash Flow | -33.13B | -28.64B | 2.65B | -32.94B | -28.33B |
| Financing Cash Flow | -35.17B | -26.24B | -57.50B | -10.93B | -16.16B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
76 Outperform | ¥456.87B | 19.34 | 14.28% | 2.40% | 8.33% | 27.80% | |
74 Outperform | ¥647.22B | 36.23 | 5.25% | 2.13% | -7.11% | 68.57% | |
73 Outperform | ¥886.86B | 21.92 | ― | 1.81% | -0.48% | -2.83% | |
72 Outperform | ¥439.61B | 32.28 | ― | 2.50% | 1.45% | 0.37% | |
71 Outperform | ¥1.28T | 21.91 | 12.13% | 1.21% | 7.54% | 13.65% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
60 Neutral | ¥356.41B | 26.70 | ― | 1.65% | 5.02% | 19.84% |